The CDL is pleased to announce the addition of five new NextGen panels, including our most comprehensive panel for Osteogenesis Imperfecta to date, the 30-gene OI and Genetic Bone Disorders Panel. The CDL offers new testing for Osteopetrosis, Cutis Laxa, Ectopia lentis, and Complex EDS-like Disorders. As always, the CDL is committed to providing the most comprehensive analysis, interpretation and follow-up of these genes and all genes involved in inherited disorders of connective tissue.
